Characteristic |
Median (inter-quartile range) or % |
Date of HAART initiation |
February 1998 (March 1997, February 2000) |
Cumulative NRTI use-years |
3.3 (1.6, 5.1) |
Cumulative zidovudine use-years |
1.0 (0.5, 1.9) |
Cumulative stavudine use-years |
0.5 (0.0, 1.0) |
Cumulative abacavir use-years |
0.0 (0.0, 0.0) |
Cumulative tenofovir use-years |
- (0.0, 0.0)
|
Cumulative PI use-years |
0.5 (0.2, 0.6) |
Cumulative NNRTI use-years |
0.0 (0.0, 0.4) |
Enrollment Period 1994-1995 |
91% |
Age, yearsa |
38.7 (33.6, 44.1) |
Race/Ethnicity
African-American
Hispanic
White
Other |
56%
25%
16%
2% |
Alcohol Use>3 drinks/weeka |
18% |
Cigarette Smokinga
Current
Former
Never |
51%
22%
27% |
Marijuana usesince last visit |
18% |
Injection drug, heroin, cocaine, or crack usesince last visit |
13% |
Quality of Lifea |
65.5 (48.4, 79.5) |
CESD> 16a |
49% |
Highest education level attained
Graduated college or higher
Some College
Completed High School
Did not complete high school |
8%
25%
31%
37% |
Have AIDSa |
40% |
CD4 cell count, cells/mm3a
<100
100-<200
200-<500
≥ 500 |
15%
18%
51%
15% |
log10HIVRNA, copies/mla |
4.2 (3.3, 4.8) |
|